DEF 14A

Company

LISATA THERAPEUTICS, INC.

Filed

June 8, 2015

Period of Report

June 8, 2015

Accession Number

0000320017-15-000050

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →